The original HER2 scoring, designated by the pathologist at the time of reporting, divided tumours into score 0 (20/50; 40%), 1+ (13/50; 26%), score 2+ ‘equivocal’ (12/50; 24%) and 3+ (5/50; 10%). The gene discussed is ERBB2; the disease is neoplasm.